SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.

Although Novo Nordisk and Eli Lilly are the main players in the GLP-1 arena, a number of other pharmaceutical companies are ...

AbbVie (NYSE: ABBV) closed out a pivotal 2024 with an excellent fourth-quarter earnings report. For the period ended Dec. 31, ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS ...

Highlights,Institutional investors have adjusted their holdings in Sage Therapeutics.,The company reported a negative net ...

Impact Partnership Wealth LLC boosted its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 13.3% during the 4th quarter, according to the company in its most recent filing with the Securities & ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...